December 17, 2025

Bridging the Digital Divide: How Collaboration and Standardization Are Shaping the Future of Biotech

The promise of cell and gene therapy is boundless, but data silos are holding it back. Standardization, interoperability, and collaboration can move data as freely as science itself.

The Medicine Maker

December 09, 2025

Hear, Hear to ‘Advancing Geriatric Oncology: Where We Have Been and Where We Are Going’

We read with interest the commentary by Stuart Lichtman, MD, FASCO,on “Advancing Geriatric Oncology: Where We Have Been and Where We Are Going,“ in the October 25, 2025 issue of The ASCO Post.1 Dr. Li...

The ASCO Post

December 09, 2025

The Diagnosis I Couldn’t Deliver: An Oncologist’s Journey Between Roles

As a medical oncologist and palliative care physician, I have spent years preparing for difficult conversations. I’ve guided patients and families through the uncertainty of cancer, helped them naviga...

The ASCO Post

December 04, 2025

ASCO Statement on the Departure of Richard Pazdur, MD, From the FDA

Dr. Pazdur has served the FDA for 26 years and is an expert in drug regulation. He is a longtime ASCO member who has been recognized with the ASCO Service Recognition Award and ASCO Public Service Awa...

The ASCO Post

December 04, 2025

Reshaping Drug Development with Mathematical Modeling

Reducing risk, increasing confidence, and enhancing precision through mathematical modeling.

The Medicine Maker

November 26, 2025

Breaking Down Barriers to Biosimilar Access

With new approvals for its denosumab biosimilars, Biocon Biologics is working to close gaps in access across Europe. Blake Leitch shares how education, collaboration, and regulatory innovation can accelerate adoption and benefit more patients.

The Medicine Maker

November 24, 2025

Access to Advanced Therapies Hinges on AI and Collaboration

AI and collaboration can transform cell and gene therapy by integrating data, improving manufacturing handoffs, and enabling personalized, scalable treatments.

The Medicine Maker

November 20, 2025

Bringing New Ideas to AAV Gene Therapy

As safety concerns and commercial doubts threaten the AAV gene therapy field, new technologies may offer a “well-rounded” solution.

The Medicine Maker

November 10, 2025

Alcohol and Cancer Risk: Is a Drop Too Much?

In 2022, Congress requested a scientific review from the National Academies of Sciences, Engineering, and Medicine (NASEM) to study the associated risks of cancer and other health conditions and the u...

The ASCO Post